What’s more difficult than curating an eloquent and versatile rotation of eveningwear? Well, building a wardrobe of go-to items that look as good as they feel for those casual, in-between days. This ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...